Acomplia, a brand name of the molecule Rimonabant and is another wonder drug apart from the previous line of obesity controllers. Acomplia has been developed by French Pharmaceutical Company, Sanofi Synthelabo and is being marketed by Sanofi Aventis worldwide. The company claims it is prescribed to reduce the weight of persons who are overweight through blocking their lusting feel towards food. The overweight people have disadvantages of other diseases like cardiovascular problems, Diabetes type ?II, palpitations on simple walks and extra tiredness etc. Acomplia is said to have minimized these problems while it is being administered on patients.

The common adherence of an obese is over craving for food than normal and it results in weight gain. As the eaters gain weight, the problems associated with overweight starts and the body starts inviting other complimentary mal-effects leading to different diseases and problems. is another product in line of cheering the obese. Actually the endocannabinoid or CB1 cannabinoid receptors are often called body pleasure centers and if excited they can cause increase in the appetite. Rimonabant molecule works in the body by blocking the CB1 Cannabinoid receptors to react to the stimulus of asking for food. Thus, the activity of craving is interrupted and the urge to demand more food by body stops immediately. This also makes the stomach to get rest from excessive food processing, giving it the metabolic relaxation. Effectively this stoppage of fresh inputs of eatables makes people to control and manage their bodyweight.

Since acts on the endocannabinoid system which is said to be responsible for tobacco dependency, can be a cure for smoking habits. As such the craving for smoking whether it is nicotine, marijuana or other mild stimulants are affected by the same body pleasure centers that are available for food urges. Hopefully Rimonabant (Acomplia) is being looked upon as smoking inhibitor. This will also make those to quit smoking who were reluctant to quit, because of fear of gaining weight.

Like every drug, Acomplia-Rimonabant has some side effects but they are mild and of short nature. People who are on Acomplia-Rimonabant medication may suffer from diarrhea, uneasiness like feeling of nausea on eating food or chocolates, vomiting on eating their earlier regular diet and dizziness. There are other side effects like increase in mood swings, depression and feelings of anxiety.

Acomplia-Rimonabant has positive side effects like increase in the HDL cholesterol which is good for heart and also results in the reduction of triglycerides. While in this succession the reduction of fasting plasma sugar levels and insulin levels were also evident as beneficial indications.

The Rimonabant has been approved in Europe and UK as ?Acomplia-Rimonabant? and in other markets like US and India as ?Zimulti? (Acomplia-Rimonabant). No wonder the case studies shows that Acomplia-rimonabant is curing the patients and especially those who are suffering some risky metabolic issues and leading themselves to cardio metabolic diseases. This drug is available through various approved vending systems including the online stores. Of course the Acomplia-Rimonabant is a wonder drug but one cannot help to go beyond 20mg daily that is EU/FDA recommended dosage.